Format

Send to

Choose Destination
Swiss Med Wkly. 2019 Mar 10;149:w20023. doi: 10.4414/smw.2019.20023. eCollection 2019 Feb 25.

Interventional treatment of mitral valve regurgitation: an alternative to surgery?

Author information

1
Department of Cardiology, Bern University Hospital, Bern, Switzerland.
2
Department of Cardiac Surgery, Bern University Hospital, Bern, Switzerland.

Abstract

Mitral regurgitation is a highly prevalent condition among elderly patients, affecting almost 10% of the general population aged 75 and older. Left untreated, severe mitral regurgitation results in high mortality and frequent hospitalisation for treatment of heart failure. Surgical treatment remains the first-line therapy for symptomatic, severe mitral regurgitation , especially for patients presenting with a primary aetiology. However, a high proportion of patients with mitral regurgitation are turned down for open-heart surgery, mainly due to advanced age, diminished left ventricular function and comorbidities. Thus, percutaneous treatment options have been recently developed as an alternative. In this article, we will review transcatheter interventional techniques at the level of the mitral valve, including implantation technique, indications and clinical results.

PMID:
30852836
DOI:
10.4414/smw.2019.20023
Free full text

Supplemental Content

Full text links

Icon for EMH Swiss Medical Publishers Ltd.
Loading ...
Support Center